Product Overview
Seratrodast | T0212 | TargetMol Chemicals
CAS: 112665-43-7
Smiles: CC1=C(C)C(=O)C(C(CCCCCC(O)=O)c2ccccc2)=C(C)C1=O
Formula: C22H26O4
Pathway: DNA Damage/DNA Repair|||GPCR/G Protein|||Immunology/Inflammation|||Metabolism|||Neuroscience
Target: COX|||Prostaglandin Receptor|||PPAR
Receptor: N/A
Bioactivity: Seratrodast (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997.
Molecular Weight: 354, 446
